Little is known regarding homing/engraftment and mobilization of hematopoietic stem and progenitor cells. We hypothesized that the CXC chemokine Stromal cell derived factor-1 (SDF-l/CXCL12) and its receptor CXCR4 are involved in these important and clinically relevant processes. Towards our long-term goals to modulate homing and mobilization for clinical benefit, we propose the following two Specific Aims: 1. Evaluate roles of SDF-1 (CXCL12) and its receptor, CXCR4, in the processes of stem and progenitor cell homing, engraftment and growth factor-induced or spontaneous mobilization in mice by modulating expression and activities of SDF-1 and/or CXCR4 in stem/progenitor cells and/or the microenvironment. To these goals, use the SDF-1 antagonist AMD 3100 as well as RSV-SDF-1 and LCK-SDF-1 transgenic mice to evaluate homing and engraftment, and AMO 3100 and G-CSF to evaluate mobilization in mice of differing genetic backgrounds as well as in RSV-SDF-1 and LCK-SDF-1 transgenic mice, and CCR1 -/- mice. 2. Evaluate mechanisms involved in SDF-1/CXCR4 effects on chemotaxis and mobilization of hematopoietic stem and progenitor cells in mice by determining intracellular signaling molecules and pathways involved in these effects in normal primary stem and progenitor cells, and by use of mice with functional deletions in selected intracellular signaling molecule. To the goals of aim 2, evaluate signaling in phenotypically defined populations of primary stem and progenitor cells using multivariate intracellular and cell surface flow cytometry, and use cells from mice functionally deleted in specific intracellular molecules or normal cells transduced with genes expressing dominant negative or activated forms of intracellular molecules. Also use intracellular gene deleted mice to assess their response to in viva mobilization with AMD 3100 and/or GCSF. These studies should clarity the relevance of SDF-1 and CXCR4 for homing/engraftment and mobilization of primary stem/progenitor cells.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Badman, David G
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Schools of Medicine
United States
Zip Code
Lakhter, Alexander J; Lahm, Tim; Broxmeyer, Hal E et al. (2016) Golgi Associated HIF1a Serves as a Reserve in Melanoma Cells. J Cell Biochem 117:853-9
Mehta, S A; Christopherson, K W; Bhat-Nakshatri, P et al. (2007) Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Oncogene 26:3329-37
Broxmeyer, Hal E; Sehra, Sarita; Cooper, Scott et al. (2007) Aberrant regulation of hematopoiesis by T cells in BAZF-deficient mice. Mol Cell Biol 27:5275-85
Tao, Wen; Evans, Barbara-Graham; Yao, Jing et al. (2007) Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hematopoietic stem cells, whereas DsRed-express fluorescent protein is not. Stem Cells 25:670-8
Ito, Shigeki; Mantel, Charlie R; Han, Myung-Kwan et al. (2007) Mad2 is required for optimal hematopoiesis: Mad2 associates with c-Kit in MO7e cells. Blood 109:1923-30
Broxmeyer, Hal E; Cooper, Scott; Hangoc, Giao et al. (2006) Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins. Exp Hematol 34:1078-84
Okabe, Seiichi; Tauchi, Tetsuzo; Ohyashiki, Kazuma et al. (2006) Stromal-cell-derived factor-1/CXCL12-induced chemotaxis of a T cell line involves intracellular signaling through Cbl and Cbl-b and their regulation by Src kinases and CD45. Blood Cells Mol Dis 36:308-14
Broxmeyer, Hal E; Pelus, Louis M; Kim, Chang H et al. (2006) Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C. Exp Hematol 34:1069-77
Porecha, Nehal K; English, Kyle; Hangoc, Giao et al. (2006) Enhanced functional response to CXCL12/SDF-1 through retroviral overexpression of CXCR4 on M07e cells: implications for hematopoietic stem cell transplantation. Stem Cells Dev 15:325-33
Basu, Sunanda; Broxmeyer, Hal E (2005) Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12. Blood 106:485-93

Showing the most recent 10 out of 100 publications